Daily Stock Analysis, PAHC, Phibro Animal Health Corp, priceseries

Phibro Animal Health Corp. Daily Stock Analysis
Stock Information
Open
20.89
Close
20.60
High
21.00
Low
20.60
Previous Close
20.94
Daily Price Gain
-0.34
YTD High
22.03
YTD High Date
Feb 15, 2022
YTD Low
18.14
YTD Low Date
Feb 4, 2022
YTD Price Change
-0.12
YTD Gain
-0.59%
52 Week High
30.50
52 Week High Date
Jul 1, 2021
52 Week Low
18.14
52 Week Low Date
Feb 4, 2022
52 Week Price Change
-2.54
52 Week Gain
-10.99%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 25. 2017
26.30
Jun 12. 2017
32.11
33 Trading Days
22.05%
Link
LONG
Apr 3. 2018
37.00
Apr 25. 2018
39.38
16 Trading Days
6.43%
Link
LONG
Mar 11. 2019
27.78
Mar 25. 2019
29.57
10 Trading Days
6.43%
Link
LONG
Mar 26. 2020
19.19
Apr 14. 2020
21.92
12 Trading Days
14.23%
Link
LONG
Dec 31. 2020
18.93
Jan 27. 2021
20.32
17 Trading Days
7.34%
Link
Company Information
Stock Symbol
PAHC
Exchange
NasdaqGM
Company URL
http://www.pahc.com
Company Phone
201-329-7300
CEO
Jack C. Bendheim
Headquarters
New Jersey
Business Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ 07666
Sector
Equity
Industry Category
Health Services
Industry Group
Specialized Health Services
CIK
0001069899
About

Phibro Animal Health Corp. develops, manufactures and markets animal health pharmaceutical and nutritional products. It offers products for food animals including poultry, swine, beef and dairy cattle and aquaculture. The company's products inhibit the growth of pathogenic bacteria that cause bacterial infections in animals; anticoccidials, which inhibit the growth of coccidian. Phibro Animal Health was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Description

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey.